Please try another search
Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel. Oncimmune Holdings plc was incorporated in 2015 and is based in Leeds, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Alistair Macdonald | 53 | 2022 | Non-executive Chairman |
Martin John Gouldstone | 56 | 2023 | CEO & Director |
Nora Pashayan | - | 2018 | Member of Scientific Board |
Parag Mallick | 45 | 2019 | Member of Scientific Board |
John Howard Goold | 52 | 2023 | Independent Non-Executive Director |
Richard M. Roope | - | 2018 | Member of Scientific Board |
Ola S. Winqvist | 61 | 2018 | Member of Scientific Board |
Sally Waterman | 65 | 2023 | Senior Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review